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ABSTRACT
Sertoli cells are critical for testicular function and maintenance of
the spermatogenic process. The induction of Sertoli cell differentiation in the embryo promotes testicular development and male sex
determination. The progression of Sertoli cell differentiation during
puberty promotes the onset of spermatogenesis. The maintenance of
optimal Sertoli cell differentiation in the adult is required for spermatogenesis to proceed. The current study was designed to investigate the transcriptional regulation of Sertoli cell differentiation
through the analysis of a previously identified marker of differentiation, transferrin gene expression. Sertoli cells produce transferrin to
transport iron to developing spermatogenic cells sequestered within
the blood-testis barrier.
The transferrin promoter was characterized and found to contain
two critical response elements, designated Sertoli element 1 (SE1)
and Sertoli element 2 (SE2). Through sequence analysis, SE2 was
found to contain an E-box response element, which has been shown
to respond to basic-helix-loop-helix (bHLH) transcription factors. The
bHLH proteins are a class of transcription factors associated with the
induction and progression of cell differentiation. bHLH proteins
dimerize through the conserved helix-loop-helix region and bind DNA
through the basic region. Nuclear extracts from Sertoli cells were
found to cause an E-box gel shift when the cells were stimulated to
differentiate in culture, but not under basal conditions. The SE2 gel
shift of Sertoli nuclear extracts was competed with excess unlabeled
SE2 or E-box DNA fragments. Several Sertoli nuclear proteins associate with the SE2 gel shifts, including 70-, 42-, and 25-kDa proteins. Therefore, the critical SE2 element in the transferrin promoter
is an E-box element capable of binding bHLH transcription factors.

The ubiquitously expressed E12 bHLH protein dimerizes with numerous cell-specific bHLH factors. A Western blot analysis demonstrated that E12 was present in Sertoli cell nuclear extracts and
associated with the SE2 gel shift. A ligand blot of Sertoli cell nuclear
extracts with radiolabeled E12 had apparent bHLH proteins when the
cells were stimulated to differentiate. The E-box sequence in the SE2
fragment of the transferrin promoter was CATCTG and was similar
in gel shifts to the consensus E-box elements (CANNTG) previously
characterized. A bHLH inhibitory factor (Id) competed and inhibited
formation of the Sertoli cell nuclear extract E-box gel shift. To extend
this observation, Id protein was overexpressed in cultured Sertoli
cells. A transferrin promoter chloramphenicol acetyltransferase construct was used to monitor Sertoli cell function. The presence of Id
suppressed the activation of the promoter induced by Sertoli differentiation factors. Therefore, the inhibition of Sertoli bHLH factors by
Id suppressed Sertoli cell differentiated function, as measured by
transferrin expression. An E-box-chloramphenicol acetyltransferase
construct was also found to be active in Sertoli cells when cells were
induced to differentiate. Screening the computerized nucleotide data
bases demonstrated that putative E-box response elements are
present in the promoters of a large number of Sertoli cell differentiated genes.
In summary, a critical E-box response element has been identified
in the transferrin promoter that can be activated by bHLH factors (e.g.
E12) present in Sertoli cells. Inhibition of Sertoli bHLH factors by Id
suppresses Sertoli cell differentiated function (i.e. transferrin expression), suggesting that bHLH transcription factors may be important
in regulating Sertoli cell differentiated functions. (Endocrinology 138:
667– 675, 1997)

T

of factors have been shown to influence Sertoli differentiated
function, the transcriptional regulation of Sertoli cell differentiation has not been rigorously investigated. Several genes
that are apparently involved in initial determination of Sertoli cell fate are SRY (8), Wilms’ tumor antigen (9), and
possibly Pax-2 (10), but the specific mechanisms and factors
involved in detemination of the fate of the Sertoli cell are
unknown. FSH has a role in the progression of Sertoli differentiation and can regulate genes through cAMP response
elements (11) as well as promote immediate early genes, such
as c-fos (12–14). Another approach has been to examine the
regulation of promoters of Sertoli cell-specific genes, such as
Tf (15), FSH receptor (16), and androgen-binding protein
(17). However, Sertoli cell-specific transcription factors and
response elements remain to be fully elucidated. PModS is a
testicular paracrine factor produced by peritubular myoid
cells (18, 19) that has been shown to influence Sertoli cell
differentiated function (19, 20). Recently, a PModS preparation has been shown to act on the Sertoli cell by inducing c-fos
expression involving the serum response element of the c-fos

HE SERTOLI cells (1, 2) form the basal and apical surface
of the seminiferous tubule and provide the cytoarchitectural arrangements for the developing germinal cells (3).
Tight junctional complexes between the Sertoli cells contribute to the maintenance of a blood-testis barrier (4) and create
a unique environment within the tubule (5). Due to the
blood-testis barrier, Sertoli cells produce a number of transport proteins to deliver nutrients to germ cells (6), including
transferrin (Tf) to transport iron (7). As the Sertoli cell differentiates during pubertal development, differentiated
functions, such as Tf expression, increase and are optimal in
the adult to maintain testicular function. Although a number
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promoter and intermediate transcription factors acting at
unique response elements on the Tf promoter (21). The current study characterized these Tf promoter response elements and investigated the intermediate transcription factors. One of the response elements on the Tf promoter was
identified as an E-box sequence that binds basic-helix-loophelix (bHLH) transcription factors.
bHLH proteins are a class of transcription factors previously shown to be involved in cell-specific transcriptional
control in a number of tissues, including muscle and brain
(22–25). An example in muscle is a family of bHLH transcription factors (i.e. the MyoD family) that when expressed
are sufficient to orchestrate the coordinated expression of
most, if not all, muscle differentiated functions (26). Overexpression of MyoD-related genes can cause a fibroblast cell
to turn into a muscle cell (27). Another example is NeuroD,
which promotes neural cell differentiation and phenotype
(28). These and a number of other observations have suggested that basic HLH transcription factors play important
roles during development in many organs. An example relevant to the current study is the requirement for bHLH
proteins in sex determination and gonadal development in
Drosophila (29, 30). This observation provides additional support for the proposed hypothesis of an important role for
bHLH factors in Sertoli cell differentiation.
The bHLH proteins have a conserved helix-loop-helix domain essential for dimerization of different bHLH proteins as
well as a basic domain that mediates DNA binding to a
common hexanucleotide sequence (CANNTG) known as the
E-box. An inhibitory class of HLH proteins (Id) lacks the
basic region and prevents DNA binding after dimerization
with a bHLH protein (31, 32). Therefore, Id negatively regulates bHLH proteins by preventing them from binding to
DNA. The bHLH proteins generally form heterodimers between ubiquitously expressed bHLH proteins, such as E12 or
E47, and cell-specific bHLH proteins, such as MyoD for muscle development or NeuroD for neural development. The
bHLH heterodimer formed will then bind to an E-box response element and promote cell- or tissue-specific gene
expression. Often factors that influence cell proliferation will
influence bHLH expression (33, 34). The results presented
here suggest that hormones and a paracrine factor produced
by peritubular cells may influence Sertoli cell differentiated
function (e.g. Tf expression) through bHLH-type transcription factors.
Materials and Methods
Cell preparation and culture
Sertoli cells were isolated from the testis of 20-day-old rats by sequential enzymatic digestion (35) with a modified procedure described
by Tung et al. (36). Decapsulated testis fragments were digested first with
trypsin (1.5 mg/ml; Life Technologies, Gaithersburg, MD) to remove the
interstitial cells and then with collagenase (1 mg/ml type I; Sigma
Chemical Co., St. Louis, MO) and hyaluronidase (1 mg/ml; Sigma).
Sertoli cells were then plated under serum-free conditions in 24-well
Falcon plates (Falcon Plastics, Oxnard, CA) at 1 3 106 cells/well. Cells
were maintained in a 5% CO2 atmosphere in Ham’s F-12 medium (Life
Technologies) with 0.01% BSA at 32 C. Sertoli cell were left untreated
(control) or treated with either FSH (100 ng/ml; oFSH-16, National
Pituitary Agency) or PModS (S300; 50 mg/ml). These optimal concentrations of FSH and PModS (S300) have previously been shown to
dramatically stimulate cultured Sertoli cell differentiated function (19,

Endo • 1997
Vol 138 • No 2

20). The cells were cultured under serum-free conditions for a maximum
of 5 days, with a medium change and treatment after 48 h of culture. Cell
number and viability did not change during culture in the absence or
presence of treatment (19, 20).

Plasmids
The E-box-chloramphenicol acetyltransferase (CAT) reporter plasmid was constructed by ligating the Tf E-box oligonucleotide (CATCTG;
15 bp flanking on either side) at the HindIII site in the pCAT enhancer
(Promega, Madison, WI) plasmid. The 2581-bp mouse Tf (mTf)-CAT
reporter plasmid (pUC8-CAT) and the human GH reporter plasmid
containing the 23.0 kilobase (kb) sequence of the mTf promoter were
provided by Dr. G. Stanley McKnight (University of Washington,
Seattle, WA). The CAT reporter plasmid used in the current study
containing 22.6-kb mTf promoter was constructed by ligating the 2-kb
upstream HindIII-HindIII fragment from the 3-kb mTf promoter in the
upstream HindIII site of 2581 bp mTf-CAT (21). The pREP Id-1S (Id-1
sense), pREP Id-1AS (Id-antisense), and recombinant E12 were provided
by Dr. Jay Cross (McGill University, Montreal, Canada). The GST-Id-2
fusion plasmid was kindly provided by Dr. Mark Israel (University of
California-San Francisco).

Transfections and CAT assays
Sertoli cells cultured for 48 h were transfected with a reporter gene
construct by the calcium phosphate method coupled with hyperosmotic
shock (10% glycerol) as previously described (37) for Sertoli cells (21).
Various treatments were subsequently added, and cells were incubated
for an additional 72 h before harvesting for CAT assays. Assay of CAT
activity was performed with the [14C]chloramphenicol conversion, as
previously described (21). The average conversion of CAT substrate for
treated cells ranged between 20 –30% conversion. This assay was linear
with the protein concentration used.

Gel mobility shift assay
Gel shift assays were performed with nuclear extracts of isolated
Sertoli cells. The Sertoli cells were isolated as described above and
cultured in 150 3 20-mm tissue culture dishes (Nunclon). The cells were
treated after 48 h in culture with FSH or S300; controls were not treated.
After 72 h, the cells were scrapped off the tissue culture dishes and
washed once with PBS. The nuclear extracts of these cells were then
prepared as described by Guillou et al. (38). Typically, 70 –100 mg protein
were obtained from 108 plated cells. The 35S-labeled nuclear protein was
obtained by culturing the cells in Ham’s F-12 lacking cysteine and
methionine. 35S-Labeled cysteine and methionine were added, and the
cells were cultured, and nuclear extracts were prepared as described
above. The double stranded DNA probes used in gel retardation assays
were the Tf E-box (CATCTG) containing flanking sequence
(CCGGGCTCCATCTGCAGCCT), muscle creatine kinase (MCK) E-box
(CACCTG) containing flanking sequence (GATCCCCCCAACACCTGCTGCCTGA), mutated Tf E-box (CGCCGG) containing flanking sequence (CGGGCTGCGCCGGGAGCCCGG), mutated MCK E-box
(CGCCGT) containing flanking sequence (GATCCCCCCAACGCCGTCTGCCTGA), and the Sertoli element 2 (SE2) fragment of the mTf
promoter (between 21763 and 21514 bp). The single stranded oligonucleotides were 59-32P end-labeled with [g-32P]ATP (150 mCi/ml; New
England Nuclear, Boston, MA) and polynucleotide kinase. The complementary oligonucleotides were annealed, electrophoretically purified, and used as probes in gel shift assays. The SE2 fragment was first
dephosphorylated with alkaline phosphatase and then phosphorylated
using [g-32P]ATP (150 mCi/ml) and polynucleotide kinase. The labeled
fragment was electrophoretically purified and used as a probe.
The gel retardation assay used was a modification of the protocol
described by Garner and Rezvin (39). The final reaction volume of 20 ml
contained 0.5 ng (;50,000 cpm) 59-32P-labeled double stranded probe,
100 ng sonicated salmon sperm DNA, 2 mg poly(dI-dC) (U.S. Biochemical Corp., Cleveland, OH), 20 mg BSA, 20 mm HEPES (pH 8.0), 4 mm
Tris (pH 7.9), 50 mm KCl, 600 mm EDTA and EGTA, 500 mm dithiothreitol, and 5 mg Sertoli cell nuclear proteins. After incubation at room
temperature for 20 min, 5 ml of the reaction were electrophoretically
separated on a nondenaturing 5% polyacrylamide gel in 0.5 3 TBE. The
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gel was dried and autoradiographed. For the competition experiments,
excess unlabeled oligonucleotide was added in the binding reaction. To
analyze the number of proteins binding to the Tf E-box, gel shift was
performed using 35S-labeled nuclear extracts from Sertoli cells treated
with S300. The retarded gel shift band was isolated, and the proteinDNA complexes within gel slices were then resolved by SDS-PAGE and
visualized by autoradiography.

Ligand and Western blots
Ten micrograms of Sertoli cell nuclear proteins were size-fractionated
on a 12% discontinuous SDS-polyacrylamide gel. The proteins were then
transferred to 0.2-mm nitrocellulose membranes (BA83, Schleicher and
Schuell, Keene, NH). These membranes were used for ligand and Western blots.
Ligand blot. A ligand blot using labeled E12 was used to study the
presence of bHLH proteins in Sertoli cell nuclear extracts. The membrane
was blocked with 5% milk-HBB buffer (20 mm HEPES, pH 7.7; 5 mm
MgCl2; 25 mm NaCl; and 1 mm dithiothreitol) before probing with
recombinant g-32P-labeled E12 in Hyb75 buffer (20 mm HEPES-KOH,
pH 7.7; 75 mm KCl; 0.1 mm EDTA; 2.5 mm MgCl2; 1% milk; 1 mm
dithiothreitol; and 0.05% Nonidet P-40). The recombinant E12 fusion
protein contained the bHLH domain of hamster sh PAN-2 (amino acids
509 – 649 with mutations R554A and R556A) fused to a heart muscle
kinase recognition sequence (40). This E12 fusion protein was phosphorylated by heart muscle kinase in the presence of [g-32P]ATP.
Western blot. Western blot analysis using an antibody to human E12 (SC
762, Santa Cruz Biotechnology, Santa Cruz, CA) was performed to
identify E12 in Sertoli cell nuclear extracts. The membranes were probed
for 3 h at room temperature with the E12 antibody. Antigen-antibody
complexes were identified using an enhanced chemiluminescence detection system (Amersham, Arlington Heights, IL) according to the
manufacturer’s instructions.
To determine whether E12 is one of the components of the complex
binding to the E box during gel shifts, the retarded gel shift band was
excised and loaded onto a 12% SDS-polyacrylamide gel. The size-fractionated proteins were then transferred to a 0.2-mm nitrocellulose membrane and probed with E12 antibody as indicated above.
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fied, termed SE1 and SE2, that complexed Sertoli cell nuclear
proteins when the cells were stimulated with differentiation
factors. To further analyze these response elements, the mTf
promoter was sequenced. Interestingly, a nonpalindrome
E-box sequence (CATCTG), termed Tf E-box, was identified
in SE2 located between 21587 and 21582 bp (Fig. 1). SE2 did
not contain any other common response element sequences.
A comparison of the Tf E-box sequence to other known E-box
sequences (consensus CANNTG) revealed its presence in
other promoters, such as the c-fos promoter, which can respond to bHLH (41, 42). A computerized data bank search
revealed that putative E-box response element sequences are
present in the promoters of a number of Sertoli cell-specific
genes (Table 1). However, the functional significance of these
E-box elements remains to be determined. These genes may
have the ability to respond to bHLH proteins, but this needs
to be investigated.
To address the question of whether bHLH proteins are
present in Sertoli cells, gel shift experiments were initially
performed. As shown in Fig. 2, a gel shift was observed when
a radiolabeled Tf E-box oligonucleotide, including flanking
region, was used as a probe in the binding reaction with
nuclear extracts from PModS (S300)- and FSH-stimulated
Sertoli cells. PModS (S300) is a gel filtration fraction preparation of PModS from serum-free concentrated peritubular
cell secreted proteins that has been shown previously to
dramatically stimulate Sertoli cell differentiated functions

Statistical analysis
All data were obtained from a minimum of three different experiments unless otherwise stated. Each data point was converted to a
relative CAT activity, with the mean and sem from multiple experiments
determined as indicated in the figure legends. Data were analyzed by
Student’s t test as indicated in the figure legends.

Results

Previous analysis of the 3-kb mTf promoter and its deletion mutants suggested that an upstream 1-kb fragment between 22.5 to 21.5 kb may have an important role in the
Sertoli cell-specific expression of the Tf gene (21). Within this
1-kb region, two potential cis-acting elements were identi-

FIG. 1. Sequence of SE2 of the mTf promoter. SE2 is located between
21763 and 21514 bp upstream of the transcriptional start site on the
promoter. The relation to SE1 and the cAMP response element (CRE)
is shown. The E-box response element (CATCTG) located in SE2 is
underlined.

TABLE 1. Putative E-box response elements in promoter regions of genes involved in Sertoli cell differentiation
Promoter

Species

E-box sequence

Location (bp)

Transferrin
FSH receptor
Androgen binding protein
Inhibin (b-subunit)
Inhibin (a-subunit)
Mullerian inhibiting substance

Murine
Murine
RAT
RAT
RAT
Bovine
RAT

SRY (sex-determining gene)

Murine
bovine

CATCTG
CACGTG
CATCTG
CATTTG
CACGTG
CAGCTG
CAGGTG
CACCTG
CATCTG
CACATG
CATCTG
CAGCTG

21582
2261
21317, 2129
2106
284
2479
21322, 2809, 2206
21089, 2650, 2101
2961, 2898
265
2537
2188
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FIG. 2. A Tf E-box (Tf-E-box) gel shift with Sertoli cell nuclear extracts from control unstimulated cells, PModS (S300)- or FSH-treated
cells, and freshly isolated Sertoli cells from 20-day-old rats (Fresh).
Right, The gel shift with the Tf-E-box; left, the gel shift with Oct-1
oligonucleotide to confirm nuclear extract integrity. The gel shift is
representative of a minimum of three different experiments.

(21). The presence of a single shifted band suggests that FSH
and PModS (S300) promote and maintain the expression of
Sertoli cell E-box binding proteins, which will include bHLH
proteins. A similar band shift was not observed in untreated
control Sertoli cells cultured in the absence of FSH or PModS
(S300). However, an Oct-1 gel shift was observed, demonstrating the integrity of the nuclear extracts. The transcription
factors that bind an Oct-1 oligonucleotide are abundant and
provide a useful procedure to monitor the integrity of nuclear extracts and help normalize gel shift data. As previously shown, Sertoli cell number and viability did not change
during the culture period whether cells were cultured in the
absence or presence of FSH or PModS (S300). An E-box gel
shift was also detected in the nuclear extracts of Sertoli cells
freshly isolated from 20-day-old midpubertal rats (Fig. 2).
Therefore, the lack of a gel shift in control cultured Sertoli
cells was due to an apparent loss of bHLH proteins during
culture. Sertoli cell differentiated functions are known to
decline in control untreated cultures (19, 20). The specificity
of the gel shift was determined by using excess unlabeled Tf
E-box oligonucleotide in the binding reaction. As shown in
Fig. 3, the unlabeled Tf E-box oligo at a 100-fold molar excess
was able to completely abolish the observed gel shift. Concentrations of unlabeled competitor less than a 100-fold molar excess resulted in partial displacement (data not shown).
Excess unlabeled SE2 was also able to displace the gel shift
observed with labeled Tf E-box (Fig. 3A). As previously
shown (21), the SE2 fragment of the Tf promoter located at
21763 to 21514 bp was able to cause a gel shift when incubated with nuclear extracts of Sertoli cells treated with
PModS (S300). This shift appeared to be due to the Tf E-box
sequence (CATCTG) present in SE2 between 21587 bp to
21582 bp. Addition of excess unlabeled Tf E-box in the
binding reaction abolished the SE2 gel shift (Fig. 3B). Excess
unlabeled Oct-1 had no effect on the gel shift (data not

FIG. 3. A, A Tf E-box (E-box) gel shift with Sertoli cell nuclear extracts from PModS (S300)-treated cells. The gel shift was displaced
with excess unlabeled E-box oligonucleotide duplex DNA or SE2 (200bp) DNA fragment. The molar ratio of unlabeled excess DNA fragment is indicated. The gel is a representation of a minimum of three
different experiments. B, An SE2 gel shift with Sertoli cell nuclear
extracts from PModS (S300)-treated cells. The gel shift was displaced
with excess unlabeled Tf E-box (Tf-E-box) with the molar excess
indicated. The gels are representative of a minimum of three different
experiments.

shown). Taken together, the observations suggest that the gel
shift observed with SE2 is due to the Tf E-box sequence.
Whether the multiple bands in Fig. 3B were due to proteolytic
degradation of the nuclear extract or different protein shifts
remains to be determined; however, all were competed with
the unlabeled E-box.
To characterize the E-box binding proteins in the gel shift,
the proteins associated with the Sertoli cell E-box gel shift
were examined. The gel shift was performed with [35S]cysteine- and [35S]methionine-radiolabeled nuclear extracts
from Sertoli cells. The shifted band from the gel shift experiment was isolated and loaded onto a 12% polyacrylimideSDS gel. A fluorograph of the gel revealed three consistently
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detected proteins of 70, 42, and 25 kDa (Fig. 4). A control of
isolating a comparable band from a displaced gel shift was
also run and showed no radiolabeled proteins (data not
shown). The width of the well and the salt concentration
needed to permit loading of sufficient amounts of sample
caused a distortion in the bands compared with crude extracts. The E-box proteins detected were not prominent
bands in the crude extract. The observation suggests that
multiple proteins appear to associate and bind to the Tf E-box
oligo nucleotide duplex. However, the specificity of binding
of these various proteins needs to be determined. A Western
blot of this gel with an E12 antibody revealed that the 70-kDa
protein was E12 (Fig. 4). A smaller 29-kDa band observed in
the Western blot of the crude extract was probably a proteolytic fragment of E-12 not capable of binding the E-box.
Recently, we also showed the presence of E12 by reverse
transcription-PCR in Sertoli cells using rat E12 primers (data
not shown). The 42- and 25-kDa proteins remain to be identified. The bands observed at 14 kDa may be a proteolytic
fragment of the larger proteins and was not always detected.
Observations from the SDS gel imply that multiple proteins
may be involved in the Tf E-box gel shift.
An alternate procedure to identify bHLH proteins in Sertoli cells involved a ligand blot with a radiolabeled bHLH
protein. The Sertoli cell nuclear extracts were electrophoretically separated on an SDS gel, blotted onto nitrocellulose,
and probed with recombinant radiolabeled E12. E12 is a
ubiquitously expressed bHLH protein found in many tissues
and forms heterodimers with cell-specific bHLH proteins. As
shown in Fig. 5, a number of different bands were observed,
indicating that Sertoli cells contain proteins that can dimerize
with E12. A control with denatured E12 showed no nonspecific binding (data not shown). The demonstration of specific

FIG. 4. A, The radiolabeled (35S-Cys/met) Sertoli cell nuclear extract
proteins that associate with a Tf-E-box gel shift electrophoretically
separated on a SDS gel and fluorographed. The gel shift-associated
proteins are shown in lane 1 (wide lane), and the total nuclear extract
is shown in lane 2. B, Western blot analysis of Sertoli cell nuclear
extracts (lane 1) and the retarded band of the gel shift assay (lane 2;
see Fig. 2) using antibody to human E12. The molecular size in
kilodaltons is shown at the left. The gel is representative of three
different experiments.
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binding with displacement of unlabeled E12 remains to be
performed. This observation supports the E-box gel shift data
and also suggests that bHLH proteins may be present in
Sertoli cells.
The Tf E-box has the E-box consensus sequence, but is not
palindromic like the more classical CACCTG or CAGCTG
found in the enhancer of MCK (43) and troponin-1 (44). To
investigate whether the bHLH binding properties to the classical (CACCTG) E-box of MCK are similar to those of the Tf
(CATCTG) E-box, gel shifts were performed in which the
MCK E-box, including flanking region, was used as a probe,
and excess unlabeled Tf E-box was added in the binding
reaction. As shown in Fig. 6, a gel shift was observed when
either MCK E-box or Tf E-box was used as probes, and the
gel shifts could be displaced by adding excess unlabeled
MCK E-box or Tf E-box. This suggests that the Sertoli bHLH

FIG. 5. An E12 radiolabeled ligand blot of Sertoli cell nuclear extract
proteins electrophoretically separated on a SDS gel and autoradiographed. The Sertoli cell nuclear extracts were isolated from control
untreated (Cont) and PModS (S300)-treated cells. The molecular size
(kilodaltons) is listed at the left. The gel is representative of three
different experiments.

FIG. 6. A gel shift with Tf-E-box or MCK-E-box with Sertoli cell
nuclear extracts from cells treated with PModS (S300). Excess unlabeled Tf-E-box (Tf) or MCK-E-box (MCK) is indicated and displaced
the gel shift. The gel is representative of three different experiments.
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proteins have binding properties to the Tf E-box similar to
those to the MCK E-box and further strengthens the observations that the Tf E-box is active, and bHLH proteins are
present in Sertoli cells.
Further analysis of the specificity of the Sertoli cell E-box
gel shift used a mutated E-box (CGCCGG) that had alterations in the critical (CANNTG) E-box sequence. This was
performed with both the Tf E-box and MCK E-box sequences.
As shown in Fig. 7, these mutated E-box oligonucleotide
duplex DNA fragments could not promote a gel shift with
Sertoli cell nuclear extracts. The mutated E-box fragments
also could not displace the Sertoli bHLH gel shifts promoted
with intact Tf E-box or MCK E-box sequences (Fig. 7). Therefore, the critical nucleotides in the (CANNTG) E-box consensus sequence are functionally important for the Tf E-box
sequence.
To investigate the functional significance of bHLH proteins in Sertoli cells, the inhibitory bHLH protein Id was
used. Recombinant Id protein was produced in a glutathione
transferase (GST) fusion protein bacterial system. The recombinant GST-Id protein was added to the binding reaction
of a Sertoli E-box gel shift experiment. As shown in Fig. 8, the
presence of the GST-Id inhibited the ability of a Tf E-box gel
shift to form. The GST-Id protein alone also did not cause a
gel shift, as expected. A control gel shift with Oct-1 was not
effected by the GST-Id construct. Therefore, the presence of
Id can prevent the Sertoli bHLH proteins from binding to the
Tf E-box. This information was then used to design an experiment to inhibit Sertoli bHLH protein actions in vitro.
To assess the functional significance of bHLH proteins in
Sertoli cell differentiation, the Sertoli cells were cultured and
transfected with a Tf promoter CAT construct (Tf-CAT) as a

FIG. 7. An E-box (E-box) gel shift with Sertoli cell nuclear extracts
from PModS (S300)-treated cells. The Tf-E-box (Tf) caused a gel shift
that could not be displaced with mutated Tf-E-box (Tf*E-box) or mutated MCK-E-box (MCK*E-box). The mutant Tf E-box (Tf*) or MCKE-box (MCK*) also did not cause a gel shift. The gel is representative
of two different experiments.
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marker of Sertoli cell differentiation. The cells were also
cotransfected with an Id expression plasmid driven by the
retroviral RSV promoter to overexpress Id in the Sertoli cells.
As a control, both sense Id that generates a functional protein
and antisense Id that generates a nonfunctional protein were
used. As expected, PModS (S300) stimulated the Tf-CAT
activity, reflecting its ability to promote Sertoli cell differentiation (Fig. 9). Relative CAT activity is based on levels of
CAT in transfected control unstimulated cells set at 1.0.
When Id was overexpressed in the Sertoli cells, approximately a 50% inhibition in the ability of PModS (S300) to
activate Tf-CAT was observed (Fig. 9). In contrast, the control

FIG. 8. A Tf E-box gel shift with Sertoli cell nuclear extracts from cells
treated with PModS (S300) and incubated in the absence (S300) or
presence of GST-Id (S3001GST-Id). GST-Id alone did not cause a gel
shift. The data are representative of two different experiments.

FIG. 9. The expression of a Tf promoter-CAT (Tf-CAT) construct in
Sertoli cells cultured in the absence (Control) or presence of PModS
(S300) or FSH. CAT activity is expressed as the relative CAT activity
based on the CAT activity in control untreated cultures, which was set
at 1.0. The cells were transfected with Tf-CAT alone or with Tf-CAT
plus Id-sense (Id-S) or Id-antisense (Id-AS) expression plasmids. This
is the mean 6 SEM from three different experiments, performed in
duplicate. **, P , 0.01; ***, P , 0.001 (statistically significant difference from Tf-CAT alone within the treatment group).

SERTOLI CELL DIFFERENTIATION AND bHLH FACTORS

antisense Id had no effect on PModS (S300)-induced Tf-CAT
activity. Similar observations were found with FSH-stimulated Sertoli cells (Fig. 9). Therefore, the presence of Id inhibited the Sertoli cell E-box binding proteins (e.g. bHLH)
from binding to the Tf E-box and activating the Tf promoter.
Another experiment to assess the functional significance of
bHLH proteins in Sertoli cells involved the transient transfection of an E-box CAT construct. CAT activity is under the
control of the E-box and the binding of bHLH proteins.
Cultured Sertoli cells were treated with regulatory agents to
monitor the E-box CAT activity. As found with the Tf promoter CAT construct above, both FSH and PModS (S300)
stimulated E-box CAT activity (Fig. 10). A CAT plasmid not
containing the E-box was also transfected as a control (data
not shown), and the CAT activity of this control plasmid was
subtracted from the CAT activity associated with the E-box
CAT construct. The stimulation of the E-box-CAT construct
(Fig. 10) confirms that FSH and PModS (S300) can induce the
apparent production and/or activation of Sertoli cell bHLH
proteins and that the Sertoli cell bHLH proteins identified are
functionally active. This observation also supports a role for
bHLH proteins in the control of Sertoli cell differentiated
functions.
Discussion

During embryonic development the Sertoli cells are derived from a mesenchymal to epithelial transition in the
bipotential gonad. This initial induction of Sertoli cell differentiation involving SRY is one of the first steps in male sex
determination and testicular development. Subsequently,
the Sertoli cells form sex cords and produce essential components, such as Mullerian inhibitory substance, to promote
male reproductive tract development. After embryonic development, the Sertoli cells prepubertally are in a growth
phase and maintain a low level of differentiated function.
The progression of Sertoli cell differentiation is promoted at

FIG. 10. The expression of an E-box-CAT construct (p-CAT Enh Ebox) in Sertoli cells cultured in the absence (Control) or presence of
FSH (FSH) or PModS (S300). CAT activity is expressed as the relative
CAT activity based on that in control untreated cultures, which was
set at 1.0. A representative of three experiments is presented. ***, P ,
0.001 (statistically significant difference from E-box CAT activity in
control cultures).
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the onset of puberty. Differentiated functions increase to an
optimal level that is maintained in the adult to control testicular function and the process of spermatogenesis. Whether
the induction of Sertoli cell differentiation during embryonic
development is distinct or involves similar mechanisms as
the progression and maintenance of differentiation during
pubertal development and in the adult remains to be elucidated. The current study used midpubertal rat Sertoli cells
and, thus, directly relates to the progression and maintenance of Sertoli cell differentiation. Future studies will be
required to make comparisons with the induction of differentiation in the embryo. A preliminary experiment, however,
demonstrated that bHLH proteins were present in the embryonic testis using the SE2 gel shift (45).
Sertoli cells have a large number of differentiated functions that generally increase to optimal levels during pubertal development. Previously, Tf expression was shown to be
a useful marker of Sertoli cell differentiation and is stimulated by regulatory agents known to promote Sertoli cell
differentiation (7). To investigate the transcriptional regulation of Sertoli cell differentiation, the promoters for various
Sertoli cell genes have been analyzed, including the Tf promoter (15, 46 – 49). Analysis of the proximal 600-bp human Tf
promoter demonstrated a distinct regulation between hepatocytes and Sertoli cells (48, 49). The current study investigated the 3-kb mTf promoter and focused on two response
elements previously shown to be critical, termed SE1 and SE2
(21, 45). Previously, the peritubular cell product PModS was
found to promote a gel shift and activate SE1 and SE2 (21).
In the current study, FSH was also found to promote a gel
shift with SE2. Sequence analysis demonstrated that SE1 did
not contain any known response element sequences (data not
shown); however, SE2 was found to contain an E-box
(CATCTG) sequence.
The E-box is the response element used by the bHLH class
of transcription factors. The Sertoli cell nuclear extract SE2
gel shift could be displaced with a consensus E-box oligonucleotide. In addition, a consensus E-box oligonucleotide
promoted a gel shift that could be displaced with SE2. A
mutant E-box could not promote a gel shift or displace the
SE2 or E-box gel shifts. Therefore, the E-box appears to be the
response element in SE2 responsible for the gel shift and
activation of the Tf promoter. Previously, deletion mutant
analysis demonstrated that a promoter construct containing
SE2 was the most active region in the Tf promoter (21).
Whether SE2 may interact with other elements, such as SE1,
remains to be investigated. Interestingly, a computerized
data search of the promoter sequences of a number of other
Sertoli differentiated genes demonstrated that putative Ebox elements are present in all of those examined. This included embryonic genes, such as SRY and Mullerian inhibitory substance, and adult functional genes, such as
androgen-binding protein and inhibin/activin. The demonstration of a critical E-box element in the Tf promoter as well
as potential elements in other Sertoli cell genes led to the
hypothesis that bHLH proteins may be involved in Sertoli
cell differentiation.
The bHLH class of transcription factors has been shown to
induce and regulate the differentiation of a number of tissues
and cell types (22–25). Examples include the MyoD family,
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which promotes muscle cell differentiation (22, 23, 26), and
NeuroD, which promotes neural cell differentiation (28).
Therefore, cell-specific bHLH proteins can promote cell-specific differentiation. The possibility that Sertoli cell differentiation may be influenced by bHLH proteins was initially
investigated by identifying the presence of Sertoli cell bHLH
proteins. The ability of Sertoli cell nuclear extracts to promote
an E-box gel shift confirmed the presence of bHLH proteins
in Sertoli cells. Both PModS (S300)- and FSH-treated Sertoli
cells promoted an E-box gel shift, whereas control nontreated
cultures had no gel shift. This observation supports a role for
bHLH proteins in Sertoli cells, as both PModS (S300) and FSH
influence Sertoli cell differentiation. The midpubertal 20day-old rat Sertoli cells are differentiated in vivo, so they
would be expected potentially to have bHLH proteins. Nuclear extracts from freshly isolated Sertoli cells did cause an
E-box gel shift. Therefore, nontreated control cultured Sertoli
cells appear to have lost the ability to produce the bHLH
proteins that promote the gel shift. This correlates with the
low level of differentiated function in control Sertoli cell
cultures previously identified (19 –21).
The E-box element in the Tf promoter was found to be
nonpalindromic (CATCTG) compared with the E-box in
MCK (CACCTG), which is palindromic. Previously, bHLH
proteins have been classified according to the ability to bind
specific E-box sequences (50, 51). Class A binds predominantly palindromic sequences (e.g. MyoD family), and class
B binds predominantly nonpalindromic sequences (e.g. myc).
Class C has unique structural properties in the bHLH domains involving the presence of proline residues (e.g. HES1
and Hairy) (51). The ability of the Sertoli cell bHLH proteins
to bind the nonpalindromic Tf E-box in a similar manner as
the palindromic MCK E-box suggests that the Sertoli bHLH
proteins have both class A- and B-type bHLH binding properties. Further characterization of the Sertoli cell bHLH proteins is necessary to confirm the class to which these bHLH
proteins belong.
The ligand blot suggested the presence of bHLH proteins
in Sertoli cells and that FSH and PModS (S300) can stimulate
the presence of E-12 binding proteins in Sertoli cells. The
E-box gel shift contained at least three radiolabeled Sertoli
cell nuclear proteins of 70, 42, and 25 kDa. Whether all of
these proteins are bHLH proteins, whether some are not
bHLH proteins but associate with the protein complex,
and/or whether the small proteins are proteolytic products
of the larger proteins remains to be investigated. Previously
characterized bHLH proteins range from 15–50 kDa in size.
The 70-kDa protein was probably E-12, as demonstrated in
the Western blot. These observations imply that bHLH proteins are present in Sertoli cells, and they have the ability to
heterodimerize with E12 and bind to an E-box.
The functional significance of Sertoli bHLH proteins was
investigated with the use of the inhibitory bHLH protein Id.
Id lacks a basic region, so upon dimerization with bHLH
proteins, it prevents binding to DNA. Initial experiments
with recombinant Id demonstrated that the presence of Id
displaced the Sertoli cell bHLH proteins from the Tf E-box gel
shift. Therefore, Id can act as an inhibitory bHLH protein in
Sertoli cells. An expression plasmid was then transfected into
Sertoli cells to overexpress Id. Overexpression of Id was
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found to inhibit the ability of both FSH and PModS (S300) to
stimulate Sertoli cell differentiation, as measured with a Tf
promoter-CAT construct. This provides direct evidence that
the Sertoli bHLH proteins are involved in the promotion of
Sertoli cell differentiation. An additional experiment used an
E-box-CAT construct transfected into Sertoli cells. Both FSH
and PModS (S300) stimulated the E-box CAT activity. Therefore, the E-box in Sertoli cells is active and induced when the
cells are stimulated to differentiate.
Combined observations demonstrate that the bHLH proteins present in Sertoli cells have a functional role in regulating Sertoli cell differentiation, as measured by Tf gene
expression. The current study provides information regarding the progression of Sertoli cell differentiation during pubertal development and the maintenance of differentiation in
the adult. Whether bHLH proteins have an important role in
embryonic Sertoli cell differentiation is currently under investigation. Characterization of the bHLH proteins in Sertoli
cells is also currently under investigation. It will be of particular interest to detemine whether Sertoli cell-specific
bHLH proteins are present and promote Sertoli cell differentiation. Further analysis of the Sertoli cell bHLH proteins
and their roles in the induction, progression, and maintenance of differentiation is anticipated to provide insight into
the transcriptional control of Sertoli cells.
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